Gotoh A - Search Results

1

Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.

Shigemura K, Isotani S, Wang R, Fujisawa M, Gotoh A, Marshall FF, Zhau HE, Chung LW. Shigemura K, et al. Among authors: gotoh a. Prostate. 2009 Jun 15;69(9):949-55. doi: 10.1002/pros.20944. Prostate. 2009. PMID: 19274665 Free PMC article.

2

Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.

Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW. Shigemura K, et al. Among authors: gotoh a. Cancer. 2007 Apr 1;109(7):1279-89. doi: 10.1002/cncr.22551. Cancer. 2007. PMID: 17326044 Free article.

3

Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.

Shigemura K, Sung SY, Kubo H, Arnold RS, Fujisawa M, Gotoh A, Zhau HE, Chung LW. Shigemura K, et al. Among authors: gotoh a. Prostate. 2007 May 15;67(7):722-31. doi: 10.1002/pros.20565. Prostate. 2007. PMID: 17342749

4

Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells.

Shigemura K, Huang WC, Li X, Zhau HE, Zhu G, Gotoh A, Fujisawa M, Xie J, Marshall FF, Chung LW. Shigemura K, et al. Among authors: gotoh a. Prostate. 2011 Dec;71(16):1711-22. doi: 10.1002/pros.21388. Epub 2011 Apr 25. Prostate. 2011. PMID: 21520153 Free PMC article.

5

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer.

Kubo H, Gardner TA, Wada Y, Koeneman KS, Gotoh A, Yang L, Kao C, Lim SD, Amin MB, Yang H, Black ME, Matsubara S, Nakagawa M, Gillenwater JY, Zhau HE, Chung LW. Kubo H, et al. Among authors: gotoh a. Hum Gene Ther. 2003 Feb 10;14(3):227-41. doi: 10.1089/10430340360535788. Hum Gene Ther. 2003. PMID: 12639303 Clinical Trial.

6

Establishment of a prostatic small-cell carcinoma cell line (SO-MI).

Okada H, Shirakawa T, Miyake H, Gotoh A, Fujisawa M, Arakawa S, Kamidono S. Okada H, et al. Among authors: gotoh a. Prostate. 2003 Aug 1;56(3):231-8. doi: 10.1002/pros.10253. Prostate. 2003. PMID: 12772193

7

Antitumor effects of etodolac, a selective cyclooxygenase-II inhibitor, against human prostate cancer cell lines in vitro and in vivo.

Shigemura K, Shirakawa T, Wada Y, Kamidono S, Fujisawa M, Gotoh A. Shigemura K, et al. Among authors: gotoh a. Urology. 2005 Dec;66(6):1239-44. doi: 10.1016/j.urology.2005.06.076. Urology. 2005. PMID: 16360450

8

[Clinical application for gene therapy in prostate cancer].

Gotoh A, Kamidono S, Chung LW. Gotoh A, et al. Hinyokika Kiyo. 1997 Nov;43(11):829-33. Hinyokika Kiyo. 1997. PMID: 9436031 Free article. Japanese.

9

Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer.

Gotoh A, Ko SC, Shirakawa T, Cheon J, Kao C, Miyamoto T, Gardner TA, Ho LJ, Cleutjens CB, Trapman J, Graham FL, Chung LW. Gotoh A, et al. J Urol. 1998 Jul;160(1):220-9. J Urol. 1998. PMID: 9628654

10

Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.

Ko SC, Gotoh A, Thalmann GN, Zhau HE, Johnston DA, Zhang WW, Kao C, Chung LW. Ko SC, et al. Among authors: gotoh a. Hum Gene Ther. 1996 Sep 10;7(14):1683-91. doi: 10.1089/hum.1996.7.14-1683. Hum Gene Ther. 1996. PMID: 8886839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters